Farmers' Rights Movement and the Convention on Biological Diversity
Journal: International Journal of Science and Research (IJSR) (Vol.10, No. 10)Publication Date: 2021-10-05
Authors : Fahima Khanum;
Page : 72-75
Keywords : Farmers Rights; Convention on Biological Diversity; Developed world; developing world;
Abstract
Farmers' Rights as a political concept emerged for the first time in the early 1980's to highlight the unremunerated innovations of farmers which were the basis of all modern plant breeding. The developed nations want to monopolise plant genetic resources. While the less - developed nations despite having more plant genetic diversity at their disposal, favour keeping plant resources in the public domain, preferring protection for traditional knowledge and farmers rights over monopoly rights for private interests. The Convention on Biological Diversity has been one of the responses of the world community to conserve the ecological basis of biological production through biodiversity conservation. It encourages countries to develop their own policies and programmes to conserve and sustain the resources within their own borders. The Convention on Biological Diversity makes provisions for the protection of farmers' rights and national rights to biodiversity. It encourages bilateral contracts between member states, where governments or corporations exploiting biological resources should provide compensation for the exploited resource and share benefits which arise from developing the resource.
Other Latest Articles
- Origin and Emplacement Conditions of the Dibilo Lithiniferous Mineralization (Liptako, Western Niger)
- Importance of Scrotal Ultrasonography in Young Adults with Retroperitoneal Lymphadenopathy
- A Study to Evaluate the Effectiveness of Structured Teaching Programme on Knowledge Regarding Breathing Exercises among Asthmatic Clients in Selected Hospital of Moradabad
- Perspectives of Teachers towards the Use of Smart Class in Rural Senior Secondary Schools of Malwa Region of Punjab State
- Comparative Analysis of Pharmacokinetic Properties of the FDA-Approved Ovarian, Fallopian Tube, and Primary Peritoneal Cancer Drugs
Last modified: 2022-02-15 18:46:47